Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
164 participants
OBSERVATIONAL
2019-03-08
2020-03-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of miRNA Expression in Endometrial Cancer
NCT04845425
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer
NCT02494791
Expressiona and Diagnostic Potential of miRNAs in NSCLC
NCT05815407
Evaluation of MCM5 in Postmenopausal Bleeding Patients
NCT05287048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endometrial cancer patients
Urinary miRNA
MiRNA detection in urine
Control group
Patients without cancer
Urinary miRNA
MiRNA detection in urine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urinary miRNA
MiRNA detection in urine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age: 18 years or older
Exclusion Criteria
* Autoimmune disorders (other than diabetes mellitus)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Cornwall Hospitals Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Cornwall Hospital
Truro, Cornwal, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018.RCHT.97.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.